ACTRN12615000391572已完成2 期
Dose-escalating, phase 2 safety study of oral lisdexamfetamine in adults with methamphetamine dependence
St. Vincent's Hospital, Sydney0 个研究点目标入组 20 人开始时间: 2015年4月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Treatment seeking for Methamphetamine (MA) dependence
- •- Fulfils ICD-10 criteria for MA dependence
- •- Self-reported MA use of >/= 14 days out of 28 days prior to enrolment
排除标准
- •- Use of dexamphetamine in the previous 4 weeks
- •- Uncontrolled medical or psychiatric conditions
- •- Unstable alcohol or other substance use, other than MA
- •- Pregnant or nursing females
- •- Moderate to severe hypertension
- •- Sensitivity/allergy to lisdexamfetamine
研究者
相似试验
进行中（未招募）
1 期
Phase I/II dose-escalation study of oral administration of the Pan-Histone Deacetylase (HDAC) Inhibitor S 78454 in Hodgkin’s Disease, non-Hodgkin Lymphoma and Chronic Lymphocytic LeukaemiaHodgkin's disease (HD) , non-Hodgkin lymphoma (NHL) and chronic lymphocytic Leukaemia (CLL)MedDRA version: 12.0Level: LLTClassification code 10020206Term: Hodgkin's diseaseMedDRA version: 12.0Level: LLTClassification code 10029547Term: Non-Hodgkin's lymphomaMedDRA version: 12.0Level: LLTClassification code 10008993Term: Chronic lymphoid leukaemiaEUCTR2009-013691-47-FRInstitut de Recherches Internationales Servier
进行中（未招募）
1 期
Phase I/II dose-escalation study of S 78454 in LymphomaHodgkin's disease (HD) , non-Hodgkin lymphoma (NHL) and chronic lymphocytic Leukaemia (CLL)MedDRA version: 18.0 Level: PT Classification code 10029547 Term: Non-Hodgkin's lymphoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0 Level: PT Classification code 10020206 Term: Hodgkin's disease System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0 Level: LLT Classification code 10008993 Term: Chronic lymphoid leukaemia System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-013691-47-GBPharmacyclics LLC135
进行中（未招募）
1 期
Phase I/II dose-escalation study of S 78454 in LymphomaEUCTR2009-013691-47-HUPharmacyclics LLC156
进行中（未招募）
1 期
Phase I/II dose-escalation study of S 78454 in LymphomaEUCTR2009-013691-47-BEPharmacyclics. LLC156
进行中（未招募）
1 期
Phase I study of LDK378 in pediatric malignancies with a genetic alteration in ALKmalignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK)EUCTR2012-002074-31-GBovartis Pharma Services AG83